Russell Investments Group’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $445K | Buy |
182,344
+142,303
| +355% | +$285K | ﹤0.01% | 2546 |
|
|
2025
Q4 | $54.9K | Buy |
40,041
+18,197
| +83% | +$24K | ﹤0.01% | 3266 |
|
|
2025
Q3 | $27.1K | Buy |
21,844
+21,650
| +11,160% | +$25.8K | ﹤0.01% | 3506 |
|
|
2025
Q2 | $219 | Sell |
194
-2,371
| -92% | -$3.15K | ﹤0.01% | 3786 |
|
|
2025
Q1 | $3.75K | Buy |
2,565
+1,978
| +337% | +$3.73K | ﹤0.01% | 3410 |
|
|
2024
Q4 | $1.25K | Buy |
+587
| New | +$1.45K | ﹤0.01% | 3506 |
|
|
2024
Q3 | – | Sell |
-80,197
| Closed | -$187K | – | 3689 |
|
|
2024
Q2 | $187K | Buy |
+80,197
| New | +$237K | ﹤0.01% | 2492 |
|
|
2022
Q4 | – | Sell |
-26,668
| Closed | -$287K | – | 2891 |
|
|
2022
Q3 | $287K | Buy |
+26,668
| New | +$362K | ﹤0.01% | 2448 |
|
|
2022
Q2 | – | Sell |
-35,400
| Closed | -$321K | – | 2877 |
|
|
2022
Q1 | $321K | Buy |
+35,400
| New | +$369K | ﹤0.01% | 2359 |
|
|
2021
Q4 | – | Sell |
-7,641
| Closed | -$196K | – | 2989 |
|
|
2021
Q3 | $196K | Buy |
7,641
+6,333
| +484% | +$150K | ﹤0.01% | 2777 |
|
|
2021
Q2 | $34K | Sell |
1,308
-56,521
| -98% | -$1.61M | ﹤0.01% | 3159 |
|
|
2021
Q1 | $2.04M | Sell |
57,829
-11,744
| -17% | -$396K | ﹤0.01% | 1868 |
|
|
2020
Q4 | $1.76M | Buy |
69,573
+41,136
| +145% | +$1.34M | ﹤0.01% | 1826 |
|
|
2020
Q3 | $1.07M | Buy |
28,437
+24,386
| +602% | +$919K | ﹤0.01% | 2040 |
|
|
2020
Q2 | $172K | Sell |
4,051
-7,808
| -66% | -$282K | ﹤0.01% | 2748 |
|
|
2020
Q1 | $230K | Sell |
11,859
-48,209
| -80% | -$1.15M | ﹤0.01% | 2492 |
|
|
2019
Q4 | $1.56M | Buy |
60,068
+23,512
| +64% | +$648K | ﹤0.01% | 1874 |
|
|
2019
Q3 | $996K | Buy |
+36,556
| New | +$1.04M | ﹤0.01% | 2003 |
|
Other funds holding ALLO
P
TGA
VCM
